FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017128344> ?p ?o ?g. }

• W2017128344 endingPage "51" @default.
• W2017128344 startingPage "51" @default.
• W2017128344 abstract "Prostaglandin-associated periorbitopathy in latanoprost users Shunsuke Nakakura,1 Minamai Yamamoto,1 Etsuko Terao,1 Nozomi Nagatomi,1 Naoko Matsuo,1 Yausko Fujisawa,1 Yuki Fujio,1 Hitoshi Tabuchi,1 Yoshiaki Kiuchi2 1Department of Ophthalmology, Saneikai Tsukazaki Hospital, Himeji, Japan; 2Department of Ophthalmology and Visual Sciences, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Japan Purpose: We investigated the incidence of prostaglandin-associated periorbitopathy (PAP) in subjects with glaucoma treated with latanoprost ophthalmic solution.Subjects and methods: One eye and the forehead in 22 subjects were evaluated. All patients had used latanoprost for more than 1 year (range, 12 to 45 months; mean, 26.0 months) and were prostaglandin F2α analogue treatment-naïve. Digital photographs of the subjects obtained before latanoprost therapy and at the last examination were compared retrospectively. Four signs of PAP (deepening of the upper eyelid sulcus (DUES), upper eyelid ptosis, flattening of the lower eyelid bags, and inferior scleral show) and supplemental side effects around the eyelids (eyelash growth, poliosis, and eyelid pigmentation) were judged to be negative or positive by three independent observers. If the observers unanimously rated a sign as positive, the result was defined as positive.Results: Twelve subjects (54.5%) had no apparent signs. Three subjects were judged to have DUES (13.6%), and two subjects each were judged to have flattening of the lower eyelid bags and eyelid pigmentation (9.0%). The other signs were judged as positive in only one subject each, respectively (4.5%). A univariate logistic regression analysis showed no significant associations between any of the signs and age, sex, or the duration of therapy.Conclusion: Latanoprost induced DUES, upper eyelid ptosis, flattening of the lower eyelid bags, inferior scleral show, and supplemental side effects around the eyelids; however, the rates of such occurrence might be relatively low. Keywords: glaucoma, prostaglandin F2α, deepening of the upper eyelid sulcus" @default.
• W2017128344 created "2016-06-24" @default.
• W2017128344 creator A5003261449 @default.
• W2017128344 creator A5007316747 @default.
• W2017128344 creator A5014111711 @default.
• W2017128344 creator A5019530919 @default.
• W2017128344 creator A5023011213 @default.
• W2017128344 creator A5035181131 @default.
• W2017128344 creator A5058429768 @default.
• W2017128344 creator A5063874968 @default.
• W2017128344 creator A5084972674 @default.
• W2017128344 date "2014-12-01" @default.
• W2017128344 modified "2023-09-25" @default.
• W2017128344 title "Prostaglandin-associated periorbitopathy in&nbsp;latanoprost users" @default.
• W2017128344 cites W1585390129 @default.
• W2017128344 cites W1966275066 @default.
• W2017128344 cites W1978593634 @default.
• W2017128344 cites W1978891777 @default.
• W2017128344 cites W1989215324 @default.
• W2017128344 cites W2001115145 @default.
• W2017128344 cites W2003916074 @default.
• W2017128344 cites W2004983136 @default.
• W2017128344 cites W2010214584 @default.
• W2017128344 cites W2017986453 @default.
• W2017128344 cites W2020636287 @default.
• W2017128344 cites W2020816860 @default.
• W2017128344 cites W2031454461 @default.
• W2017128344 cites W2038764490 @default.
• W2017128344 cites W2040322156 @default.
• W2017128344 cites W2046251173 @default.
• W2017128344 cites W2056843373 @default.
• W2017128344 cites W2058796289 @default.
• W2017128344 cites W2068829151 @default.
• W2017128344 cites W2069964798 @default.
• W2017128344 cites W2074250226 @default.
• W2017128344 cites W2077534694 @default.
• W2017128344 cites W2083146834 @default.
• W2017128344 cites W2092706340 @default.
• W2017128344 cites W2106674716 @default.
• W2017128344 cites W2116953211 @default.
• W2017128344 cites W2121182204 @default.
• W2017128344 cites W2128153823 @default.
• W2017128344 cites W2131833594 @default.
• W2017128344 doi "https://doi.org/10.2147/opth.s75651" @default.
• W2017128344 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4284030" @default.
• W2017128344 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25565768" @default.
• W2017128344 hasPublicationYear "2014" @default.
• W2017128344 type Work @default.
• W2017128344 sameAs 2017128344 @default.
• W2017128344 citedByCount "24" @default.
• W2017128344 countsByYear W20171283442015 @default.
• W2017128344 countsByYear W20171283442016 @default.
• W2017128344 countsByYear W20171283442017 @default.
• W2017128344 countsByYear W20171283442018 @default.
• W2017128344 countsByYear W20171283442019 @default.
• W2017128344 countsByYear W20171283442020 @default.
• W2017128344 countsByYear W20171283442021 @default.
• W2017128344 countsByYear W20171283442022 @default.
• W2017128344 countsByYear W20171283442023 @default.
• W2017128344 crossrefType "journal-article" @default.
• W2017128344 hasAuthorship W2017128344A5003261449 @default.
• W2017128344 hasAuthorship W2017128344A5007316747 @default.
• W2017128344 hasAuthorship W2017128344A5014111711 @default.
• W2017128344 hasAuthorship W2017128344A5019530919 @default.
• W2017128344 hasAuthorship W2017128344A5023011213 @default.
• W2017128344 hasAuthorship W2017128344A5035181131 @default.
• W2017128344 hasAuthorship W2017128344A5058429768 @default.
• W2017128344 hasAuthorship W2017128344A5063874968 @default.
• W2017128344 hasAuthorship W2017128344A5084972674 @default.
• W2017128344 hasBestOaLocation W20171283441 @default.
• W2017128344 hasConcept C118487528 @default.
• W2017128344 hasConcept C2776740260 @default.
• W2017128344 hasConcept C2777336333 @default.
• W2017128344 hasConcept C2778527774 @default.
• W2017128344 hasConcept C2779884382 @default.
• W2017128344 hasConcept C2781194658 @default.
• W2017128344 hasConcept C2781302119 @default.
• W2017128344 hasConcept C54355233 @default.
• W2017128344 hasConcept C71924100 @default.
• W2017128344 hasConcept C86803240 @default.
• W2017128344 hasConceptScore W2017128344C118487528 @default.
• W2017128344 hasConceptScore W2017128344C2776740260 @default.
• W2017128344 hasConceptScore W2017128344C2777336333 @default.
• W2017128344 hasConceptScore W2017128344C2778527774 @default.
• W2017128344 hasConceptScore W2017128344C2779884382 @default.
• W2017128344 hasConceptScore W2017128344C2781194658 @default.
• W2017128344 hasConceptScore W2017128344C2781302119 @default.
• W2017128344 hasConceptScore W2017128344C54355233 @default.
• W2017128344 hasConceptScore W2017128344C71924100 @default.
• W2017128344 hasConceptScore W2017128344C86803240 @default.
• W2017128344 hasLocation W20171283441 @default.
• W2017128344 hasLocation W20171283442 @default.
• W2017128344 hasLocation W20171283443 @default.
• W2017128344 hasLocation W20171283444 @default.
• W2017128344 hasOpenAccess W2017128344 @default.
• W2017128344 hasPrimaryLocation W20171283441 @default.
• W2017128344 hasRelatedWork W2017128344 @default.
• W2017128344 hasRelatedWork W2029271825 @default.

• next